Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP5 | Q01469 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 6/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | PDK1 | Q15118 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSPO | P30536 | 1/20 | 0.36 |
| ▸ | BCL2A1 | Q16548 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28069712 | 0.93 | FABP5 (0.45) | FABP5TSHRHTTKMT2AMEN1 | |
| SCHEMBL208874 | 0.92 | FABP5 (0.41) | FABP5TSHRHTTKMT2AMEN1 | |
| SCHEMBL1526171 | 0.91 | FABP5 (0.40) | FABP5TSHRHTTKMT2AMEN1 | |
| SCHEMBL5259956 | 0.91 | TSHR (0.37) | FABP5TSHRHTTPDK1KMT2A | |
| SCHEMBL6298094 | 0.91 | FABP5 (0.42) | FABP5TSHRHTTKMT2AMEN1 | |
| SCHEMBL5372417 | 0.90 | FABP5 (0.39) | FABP5TSHRHTTKMT2AMEN1 | |
| SCHEMBL5670740 | 0.89 | FABP5 (0.39) | FABP5TSHRHTTKMT2AMEN1 | |
| SCHEMBL3433024 | 0.88 | HSD17B10 (0.39) | FABP5TSHRHTTKMT2AMEN1 | |
| SCHEMBL4841403 | 0.87 | NPC1 (0.42) | FABP5TSHRKMT2AMEN1GPR55 | |
| SCHEMBL2637405 | 0.87 | FABP5 (0.39) | FABP5KMT2AMEN1TDP1TSPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108779150-A | The Preparation Method And Their Intermediate of Ac-D-2Nal-D-4Cpa-D-3Pal-Ser-4Aph(Hor)-D-4Aph(Cbm)-Leu-Lys(iPr)-Pro-D-Ala-NH2 | 费森尤斯卡比依普莎姆责任有限公司 | 2018-11-09 | — | — | CN | disclosed |
| CN-107602620-A | Novel iridium base complex for ECL | 霍夫曼-拉罗奇有限公司 | 2018-01-19 | — | — | CN | disclosed |
| CN-104718218-B | Novel iridium basigamy compound for ECL | 霍夫曼-拉罗奇有限公司 | 2017-10-24 | — | — | CN | disclosed |
| CN-104797587-B | Novel iridium-based complexes for ECL | 霍夫曼-拉罗奇有限公司 | 2017-10-10 | — | — | CN | disclosed |
| CN-104797587-A | Novel iridium-based complexes for ECL | ROCHE DIAGNOSTICS GMBH | 2015-07-22 | — | — | CN | disclosed |
| CN-104718218-A | New iridium-based complexes for ECL | ROCHE DIAGNOSTICS GMBH | 2015-06-17 | — | — | CN | disclosed |
| CN-103003301-A | Serum albumin binding molecules | BRISTOL MYERS SQUIBB CO | 2013-03-27 | — | — | CN | disclosed |
| CN-102223898-A | Peptides for treatment of obesity | NOVO NORDISK AS | 2011-10-19 | — | — | CN | disclosed |
| WO-2008054881-A9 | ANTIBACTERIAL AND PLASMID ELIMINATION AGENTS | PENN STATE RES FOUND (US) | 2009-06-04 | — | — | WO | disclosed |
| WO-2008054881-A2 | ANTIBACTERIAL AND PLASMID ELIMINATION AGENTS | THE PENN STATE RESEARCH FOUNDATION (US) | 2008-05-08 | — | — | WO | disclosed |
| US-6353112-B1 | 3-PHENYL-2,3-DIHYDROBENZO(D)ISOTHAIZOLES 1,1-DIOXIDES; DEPROTONATING THE NITROGEN AND LITHIATING THE ORTHO-POSITION OF AN ARYL SULFONAMIDE IN A RESIN-BOUND SECONDARY SULFONAMIDE; ALKYLATING WITH A KETONE OR ALDEHYDE; CYCLIZATION | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION | 2002-03-05 | — | — | US | disclosed |
| US-5807979-A | GENETIC ENGINEERING; HYBRIDS POLYPEPTIDES | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-09-15 | — | — | US | disclosed |